ID: ALA293263

Max Phase: Preclinical

Molecular Formula: C20H21N7O5

Molecular Weight: 439.43

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): GNF-Pf-173
Synonyms from Alternative Forms(1):

    Canonical SMILES:  Nc1nc(N)c2nc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1

    Standard InChI:  InChI=1S/C20H21N7O5/c21-16-15-17(27-20(22)26-16)23-9-12(24-15)6-3-10-1-4-11(5-2-10)18(30)25-13(19(31)32)7-8-14(28)29/h1-2,4-5,9,13H,3,6-8H2,(H,25,30)(H,28,29)(H,31,32)(H4,21,22,23,26,27)/t13-/m0/s1

    Standard InChI Key:  LGFLRHWJJKLPCC-ZDUSSCGKSA-N

    Associated Targets(Human)

    Dihydrofolate reductase 3072 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    CCRF-CEM 65223 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Lacticaseibacillus casei 578 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Dihydrofolate reductase 640 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    L1210 27553 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Dihydrofolate reductase 711 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Enterococcus faecium 13803 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Thymidylate synthase 501 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Mus musculus 284745 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 439.43Molecular Weight (Monoisotopic): 439.1604AlogP: 0.42#Rotatable Bonds: 9
    Polar Surface Area: 207.30Molecular Species: ACIDHBA: 9HBD: 5
    #RO5 Violations: 0HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
    CX Acidic pKa: 3.34CX Basic pKa: 2.88CX LogP: 0.27CX LogD: -6.04
    Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -0.17

    References

    1. Nair MG, Bridges TW, Henkel TJ, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1981)  Folate analogues altered in the C9-N10 bridge region. 18. Synthesis and antitumor evaluation of 11-oxahomoaminopterin and related compounds.,  24  (9): [PMID:6793726] [10.1021/jm00141a010]
    2. DeGraw JI, Brown VH, Tagawa H, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1982)  Synthesis and antitumor activity of 10-alkyl-10-deazaminopterins. A convenient synthesis of 10-deazaminopterin.,  25  (10): [PMID:7143361] [10.1021/jm00352a026]
    3. Nair MG, Nanavati NT, Kumar P, Gaumont Y, Kisliuk RL..  (1988)  Synthesis and biological evaluation of poly-gamma-glutamyl metabolites of 10-deazaaminopterin and 10-ethyl-10-deazaaminopterin.,  31  (1): [PMID:2447278] [10.1021/jm00396a029]
    4. DeGraw JI, Christie PH, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1990)  Synthesis and antifolate properties of 9-alkyl-10-deazaminopterins.,  33  (1): [PMID:2296020] [10.1021/jm00163a035]
    5. DeGraw JI, Colwell WT, Piper JR, Sirotnak FM..  (1993)  Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin.,  36  (15): [PMID:8340923] [10.1021/jm00067a020]
    6. Abraham A, McGuire JJ, Galivan J, Nimec Z, Kisliuk RL, Gaumont Y, Nair MG..  (1991)  Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductase.,  34  (1): [PMID:1992121] [10.1021/jm00105a035]
    7. DeGraw JI, Colwell WT, Crase J, Smith RL, Piper JR, Waud WR, Sirotnak FM..  (1997)  Analogues of methotrexate in rheumatoid arthritis. 1. Effects of 10-deazaaminopterin analogues on type II collagen-induced arthritis in mice.,  40  (3): [PMID:9022804] [10.1021/jm9505526]

    Source